The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775

PART 5 Amendment of Part 5 (marketing authorisations)

Amendment of Schedule 10 (national homoeopathic products)

55.  In paragraph 4(4)(a) of Schedule 10 (exceptions to requirement to submit safety data) insert “UK” before “marketing authorisation”.